Induction of the ABC-transporters Mdr1/P-gp (Abcb1), Mrp1 (Abcc1), and Bcrp (Abcg2) during establishment of multidrug resistance following exposure to mitoxantrone

被引:52
作者
Nieth, C [1 ]
Lage, H [1 ]
机构
[1] Inst Pathol, D-10117 Berlin, Germany
关键词
drug resistance; mitoxantrone; ABC-transporters; ABCB1; ABCC1; ABCG2;
D O I
10.1179/joc.2005.17.2.215
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Resistance to mitoxantrone is often associated with enhanced drug efflux mediated by members of the superfamily of adenosinetriphosphate-binding cassette (ABC) transporters, i.e. MDR1/P-gp (ABCB1), MRP1 (ABCC1), or BCRP (ABCG2). So far it is unclear whether the same ABC-transporter is always activated from the beginning of mitoxantrone treatment to the end of drug exposure. Here, we demonstrate that the expression of all three extrusion pumps is induced by increasing levels of mitoxantrone resistance, but in the end, merely the overexpression of a dominant single drug transporter, i.e. Mdr1/P-gp, is realized. This upregulation of Mdr1/P-gp was reflected by amplification of the Mdr1/P-gp encoding gene. Short mitoxantrone exposure demonstrated that upregulation of two different transporters, Mdr1/P-gp and Bcrp, was induced. The data indicate that mitoxantrone treatment influences the expression of several ABC-transporters, but in the end, merely a single extrusion pump will be dominant.
引用
收藏
页码:215 / 223
页数:9
相关论文
共 25 条
[1]
PHASE-I CLINICAL-TRIAL OF MITOXANTRONE - A NEW ANTHRACENEDIONE ANTI-CANCER DRUG [J].
ALBERTS, DS ;
GRIFFITH, KS ;
GOODMAN, GE ;
HERMAN, TS ;
MURRAY, E .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1980, 5 (01) :11-15
[2]
P-glycoprotein: from genomics to mechanism [J].
Ambudkar, SV ;
Kimchi-Sarfaty, C ;
Sauna, ZE ;
Gottesman, MM .
ONCOGENE, 2003, 22 (47) :7468-7485
[3]
DAVIES PJ, 1977, MOL GEN GENET, V154, P191, DOI 10.1007/BF00330836
[4]
Rationale for the use of mitoxantrone in multiple sclerosis [J].
Edan, G ;
Morrissey, S ;
Le Page, E .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2004, 223 (01) :35-39
[5]
Multidrug resistance in cancer: Role of ATP-dependent transporters [J].
Gottesman, MM ;
Fojo, T ;
Bates, SE .
NATURE REVIEWS CANCER, 2002, 2 (01) :48-58
[6]
Clinical applications of anticancer drugs targeted to topoisomerase II [J].
Hande, KR .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1998, 1400 (1-3) :173-184
[7]
Kellen John A, 2003, J Exp Ther Oncol, V3, P5, DOI 10.1046/j.1359-4117.2003.01067.x
[8]
Knutsen T, 1998, GENE CHROMOSOME CANC, V23, P44, DOI 10.1002/(SICI)1098-2264(199809)23:1<44::AID-GCC7>3.0.CO
[9]
2-6
[10]
The MRP family of drug efflux pumps [J].
Kruh, GD ;
Belinsky, MG .
ONCOGENE, 2003, 22 (47) :7537-7552